Fuld & Company Blog

MARCH 27, 2023

In 2005, Amylin and Lilly received approval for GLP-1 Exenatide as a twice-daily injection for Type 2 diabetes under the brand name Byetta. In fact, it was not until seven years later, in 2005, that Pfizer backtracked and received approval to launch sildenafil for its original cardiovascular purpose, under the brand Revatio.

Diabetes 52

Diabetes Online Pharmacies Packaging Pharmaceutical Companies 52

STAT

DECEMBER 13, 2024

billion, the highest level since tracking of funding began in 2005 and 20% more than what was seen in 2022. Just 9% came from the private sector, such as pharmaceutical companies. Specifically, the amount spent on basic research, new treatments, vaccines, and diagnostics was $1.2

Pharmaceutical Companies 253

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Pricing 253

Pharmaceutical Technology

JULY 23, 2008

The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. ” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” “For certain cancers, yes,” says Ando.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Compounding Biosimilars 40

European Pharmaceutical Review

OCTOBER 19, 2022

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment.

Biosimilars 96

Biosimilars Dosage Drug Pricing Pharmaceutical Companies 96

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 116

pharmaphorum

OCTOBER 12, 2022

As technology has evolved, biotech and pharmaceutical companies have increasingly leaned on AI to support drug development – including to make sense of the vast amounts of healthcare data available to them. Forging an AI-enabled path toward precision medicine. By 2025, pharma’s investment in AI is expected to reach $3 billion.

Drug Development 105

Drug Development Immunity Immunization Vaccines 105

PharmaShots

MAY 23, 2023

Total Revenue: $10.53B Approved Cell and Gene Therapy: Delytact Founded Year: 2005 Total Employees: ~16,450 Headquarters: Tokyo, Japan Market Cap: $68.27B Stock Exchange: TYO Daiichi Sankyo discovers and develops products for therapy areas, including Oncology and Rare Diseases.

Diabetes 58

Diabetes Immunization Immunity Pharmaceutical Companies 58

Pharma Marketing Network

JUNE 11, 2020

John Mack (PG): So, when I got laid off and as a consultant, I was working for a consulting company, helping them do websites for pharmaceutical companies in the.com bust, you know, a lot of people got laid off. It wasn’t just pharmaceutical companies and others. So that was 2005. It’s a blog.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Diabetes 52

Express Pharma

JULY 10, 2024

” According to Dr Anand, our IP framework has been getting streamlined since 2005. He also roots for more focus on emerging areas like cell and gene therapies and says that we need an ecosystem and policies that support small companies in biopharma.

Vaccines 96

Vaccines Drug Development Process Improvement Biosimilars 96

PharmaShots

MARCH 9, 2023

With more than $50 billion in annual global revenue, Janssen has grown to be the second-largest innovative pharmaceutical company under her direction. Additionally, the business has been ranked first in the pharmaceutical industry for nine years running on Fortune magazine's list of the "World's Most Admired Companies.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

pharmaphorum

MARCH 14, 2022

Roz Bekker is Vice President Commercial Strategy Infectious Diseases & Vaccines for Europe, Middle East and Africa (EMEA) at Janssen, the Pharmaceutical Companies of Johnson & Johnson. Roz joined Janssen in 2005, holding various positions across medical and commercial. About the author.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

PharmaShots

APRIL 13, 2023

model is a holistic approach to incorporate the same strategy to life science and pharmaceutical companies. A globally fast-growing, and largest pharmaceutical company in the world was created through a merger between Pfizer and Pharmacia. Model: Inspired by the industry 4.0 model, the pharma 4.0

Biosimilars 40

Biosimilars Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

European Pharmaceutical Review

AUGUST 29, 2024

2 In the first meeting of the International Health Regulations (2005) Emergency Committee about the 2024 outbreak, the WHO Director-General Dr Tedros Adhanom Ghebreyesus spoke about the 12-month extension of the current standing recommendations for mpox , which were set to expire on 20 August 2024. Internet] WHO. cited 2024Aug].

Vaccines 98

Vaccines Immunity Immunization Pharmaceutical Companies 98